We are proud to today be announcing plans to launch a new Brain Tumour Research Centre of Excellence.
Applications are being invited from UK-based researchers and their teams who will play a pivotal role in helping us achieve our vision of finding a cure for all types of brain tumours. Brain Tumour Research is investing an initial £2.5 million over five years, an investment made possible thanks to our supporters’ tireless fundraising efforts.
Sue Farrington Smith MBE, our Chief Executive, said: “We are extremely proud to be in a position to launch this call for applications for a new Centre. Thanks to our supporters, including many brain tumour patients and their families and those whose lives have been changed forever by this devastating disease, the year to June 2021 saw us deliver our best financial year yet.
“We emerged from a tumultuous year as a result of the COVID-19 lockdown with an income of £5.3 million, up 76% in the previous year. With the ongoing support of the brain tumour community, we are now working towards our ambitious aim of funding seven dedicated Centres of Excellence which will help us in our vision to find a cure, improve treatment options and bring much-needed hope to so many.”
The new Centre will grow capacity in the UK, bringing together or continuing to build a critical mass of staff, infrastructure and collaborations, while helping to transform research into this devastating disease which kills more children and adults under the age of 40 than any other cancer.
Our Director of Research, Policy and Innovation, Dr Karen Noble (pictured) said: “Our Centres support long-term research, building the critical mass of expertise needed to accelerate the journey to find a cure. Our aim is to fund an innovative and ground-breaking proposal that will contribute to transforming brain tumour research and support long-term research, building the critical mass of expertise.”
The successful Centre will be announced during Brain Tumour Awareness Month in March and we look forward to being able to update you.